anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

List

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 110,539
Current window 88,711-88,740
Pages 3,685
Rows per page 30
Component: Listclear collectionreset all
18 30 60

Component

88,711-88,740 of 110,539

filter-aware
28
Includes clinical efficacy table and RNAseq biomarker reduction chart.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
30
The table compares KT-474 (Part C) at Day 28 and 42 against external benchmarks at Week 4. Includes extensive footnote citations.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
32
Data presented as mean change from baseline with 90% CI. Includes table of mean values for delta QTc and absolute QTc.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
33
The slide uses color-coded text (orange) to emphasize key positive outcomes within the bullet points.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
35
The diagram illustrates the signaling pathways (TLR, IL-1R, B Cell Receptor) and the specific points of intervention (red asterisks) for the therapy.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
39
Includes a disclaimer/footnote regarding patient population and MYD88 mutation status.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
42
Includes a table of prevalence/incidence for specific oncology indications and a biological pathway diagram.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
45
Clinical trial safety data table showing patient counts and percentages for specific adverse events.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
47
The slide presents clinical trial results for KT-333, comparing degradation percentages across three dose levels (DL1, DL2, DL3) over two cycles.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
48
Includes bar charts for SAA/CRP reduction, a longitudinal line chart for biomarker changes, and a scatter plot showing correlation between STAT3 and SOCS3 changes.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
49
DL1-3 refers to dose levels 1-3. PK = Pharmacokinetics, PD = Pharmacodynamics, DLT = Dose-Limiting Toxicity, SAE = Serious Adverse Event.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
52
Includes a biological pathway diagram and Western blot data comparing a degrader (KT-253) to an inhibitor (DS-3032).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
53
Includes a table comparing clinical stage and potency metrics (IC50, DC50) across multiple competitors.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
54
Data presented as tumor volume growth curves and Kaplan-Meier survival plots.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
55
The slide presents five bar charts showing protein levels across different dosing regimens and time points.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
60
The image shows the Kymera Therapeutics team at their Nasdaq listing event.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
04
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Attention1 hit
08
The slide uses a background image of lemons on a tree, consistent with the company's agricultural focus.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Need1 hit
13
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · NeedLoop · Quick Win Big Bet1 hit
14
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · NeedLoop · Quick Win Big Bet1 hit
16
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · NeedLoop · Quick Win Big Bet1 hit
24
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
25
Uses a before-after-bridge structure to show the impact of a $25M investment.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
26
The slide uses a simple additive logic (sum of parts equals total) to present the growth target.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
31
The slide uses a callout box to emphasize the value proposition of the partnership.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
35
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
36
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
37
The slide explains the volatility in revenue through agricultural factors like plant physiology, weather, and supply chain disruptions.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
43
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Action1 hit
49
Includes a site plan map and architectural rendering.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Action1 hit